Working Towards an RP Treatment
Recently, the Gavin Herbert Eye Institute at UC Irvine profiled jCyte co-founder Jing Yang, MD, PhD, and retinitis pigmentosa trial participant Elaine Cain. The article highlights Dr. […]
News
jCyte Completes Enrollment for Phase 1/2a Safety Trial
November 28, 2016 – California-based regenerative medicine company jCyte has completed enrollment in a phase 1/2a trial to study the safety of its stem cell therapy candidate […]
Dr. Henry Klassen: Light at the End of the Tunnel
Dr. Henry Klassen has spent decades working on a therapy for retinitis pigmentosa. In this recent Tedx presentation, Dr. Klassen recounts some of the ups […]
Preliminary Safety Results Highlighted in Optometry Today
British website and journal Optometry Today recently published an article about the preliminary safety results from jCyte’s ongoing retinitis pigmentosa trial. The piece discussed the treatment’s safety […]
Early Trial Results Support the Safety of Cell-Based Retinitis Pigmentosa Treatment
July 15, 2016 – Regenerative medicine company jCyte and the Sue & Bill Gross Stem Cell Research Center at the University of California, Irvine report their […]
Klassen Honored as Top Ophthalmologist
The Ophthalmologist has honored Dr. Henry Klassen as one of the 100 most influential people in ophthalmology. The second annual Ophthalmologist Power List notes Dr. Klassen’s longstanding efforts to […]
Stem Cell Treatment Improves Woman’s Sight
Vanna Belton was essentially blind for more than five years before an unconventional stem cell study helped her regain limited vision. But even the study’s […]
Stem Cells used to Regrow Corneal Tissue
In two separate studies, researchers have used human cells reprogrammed to become stem cells to generate transplantable cornea tissue. The first study used the stem cell-generated tissue to repair corneas […]
jCyte Top Stem Cell Story for 2015
The Stem Cellar, California Institute for Regenerative Medicine’s (CIRM’s) official blog, recently posted its top 10 stories from 2015. Not surprisingly, a story about jCyte ranked first. The story, CIRM-Funded UC-Irvine […]
News from our Retinitis Pigmentosa Clinical Trial
I am pleased to give a quick update on the trial, which is going well. Four patients who have been severely affected by retinitis pigmentosa have […]